Found 4355 articles for: ""
Fractional Laser for Prevention of Non-melanoma Skin Cancer
September 2023 | Volume 22 | Issue 9 | Features | 953 | Copyright © September 2023
Citation: McCormick ET, Desai S, Nelson K, et al. Fractional laser for prevention of non-melanoma skin cancer. J Drugs Dermatol. 2023;22(9):953-954. doi:10.36849/JDD.2023.NVRN0923...
Read MoreTopical Treatments for Photoaged Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 867 | Copyright © September 2023
Background: Photoaging due to cumulative lifetime ultraviolet light exposure is the greatest contributing factor to facial aging. With the continued growth of the population of i...
Read MoreINDIVIDUAL ARTICLE: Vehicles Matter
September 2023 | Volume 22 | Issue 9 | Supplement Individual Articles | s5 | Copyright © September 2023
Topical medications are commonly used to manage mild-to-moderate psoriasis and serve as adjunct therapies used in combination with phototherapy and systemic treatments. Fixed-dose calcipotriene (Cal) ...
Read MoreComparison of Physicochemical Characteristics and Biostimulatory Functions in Two Calcium Hydroxyapatite-Based Dermal Fillers
September 2023 | Volume 22 | Issue 9 | Original Article | 910 | Copyright © September 2023
Background: Dermal fillers containing calcium hydroxyapatite (CaHA) are categorized as biostimulatory. However, differences in CaHA biomaterial likely affect the resultant ...
Read MoreIndividual Article: Updated Review of Topical Pharmaceuticals and Complementary and Alternative Medications for the Treatment of Onychomycosis in Both General and Special Populations in the United States
September 2023 | Volume 22 | Issue 9 | Supplement Individual Articles | SF378719 | Copyright © September 2023
Onychomycosis is a prevalent condition affecting the United States and global population. Treatment options are limited, with only 3 topical anti-fungal medications garnering approval in the US w...
Read MoreOptimizing Skin Regenerative Response to Calcium Hydroxylapatite Microspheres Via Poly-Micronutrient Priming
September 2023 | Volume 22 | Issue 9 | Original Article | 925 | Copyright © September 2023
Regenerative aesthetics aims to restore the structure and function of aging skin. Two products, Radiesse (CaHA) and NCTF 135 HA (micronutrient mesotherapy) have been established as minimally inva...
Read MoreClinical Efficacy of Topical Vitamin C on the Appearance of Wrinkles: A Systematic Literature Review
September 2023 | Volume 22 | Issue 9 | Original Article | 898 | Copyright © September 2023
Purpose: A rise in market demand for anti-aging skin care products has resulted in a proliferation of cosmeceuticals, including products that contain vitamin C. Many topicals con...
Read MoreRestoration of Aging Body Skin: Evidence-Based Development of a Topical Formulation for Improving Body Skin Quality
September 2023 | Volume 22 | Issue 9 | Original Article | 887 | Copyright © September 2023
Background: Age-related changes in body skin are emerging as important therapeutic targets. A novel topical firming and toning body lotion (FTB) has been developed to target mult...
Read MoreLong-Term Efficacy and Tolerability of a Daily Serum for Rejuvenation and Prejuvenation of Facial Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 917 | Copyright © September 2023
Onjectives: To evaluate the long-term efficacy and tolerance of an anti-aging daily serum (AADS) when used twice-daily over 12 weeks by women with moderate skin fatigue and overa...
Read MoreInsight Into Dermatology Providers' Perspectives on Approaches to Sensitive Skin: A Pilot Survey
September 2023 | Volume 22 | Issue 9 | Editorials | 950 | Copyright © September 2023
Sensitive skin (SS) is a common patient complaint; however, there are no consistent guidelines to guide dermatologists' approaches to diagnosis and management of SS. Attendees of an international...
Read MoreWATCH VIDEO ABSTRACT: Dermatoporosis: Strategies for Rebuilding the Extracellular Matrix of the Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 861 | Copyright © September 2023
Read MoreReview of Baricitinib in the Treatment of Alopecia Areata
September 2023 | Volume 22 | Issue 9 | Original Article | 935 | Copyright © September 2023
Background: Alopecia areata (AA) is a debilitating autoimmune disease that results in non-scarring hair loss. Baricitinib is the Food and Drug Administration (FDA) approved treat...
Read MoreA Randomized Control Trial Comparing the Efficacy of Platelet-Rich Plasma and 5% Topical Minoxidil for the Treatment of Androgenetic Alopecia
September 2023 | Volume 22 | Issue 9 | Original Article | 905 | Copyright © September 2023
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and has limited treatment options. Minoxidil is a common therapeutic option for AGA patients because of its availability. Plate...
Read MoreClinical Trial of Alpha and Beta Defensin Skin Care Regimen for Improvement of Periocular Wrinkles
September 2023 | Volume 22 | Issue 9 | Original Article | 874 | Copyright © September 2023
Background: Defensins recruit leucine-rich repeat-containing G protein-coupled receptor 6 positive (Lgr6+) stem cells which ultimately regenerate new basal stem cells, healthy ke...
Read MoreInto the Light: Afamelanotide and the Treatment of Erythropoietic Protoporphyria in the United States
September 2023 | Volume 22 | Issue 9 | Original Article | 941 | Copyright © September 2023
Background: Erythropoietic protoporphyria (EPP) is a rare disease that causes disabling cutaneous photosensitivity with pain and burning sensations. In 2019, afamelanotide, an &a...
Read MoreEvaluation of a Neck Cream Developed to Enhance Nitric Oxide Availability in Aging Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 881 | Copyright © September 2023
Background: To meet the unique needs of aging skin of the neck, a new neck cream that enhances nitric oxide availability has been developed to visibly improve signs of aging and ...
Read MoreFULL SUPPLEMENT: Management of Atopic Dermatitis in People with Skin of Color: A Practical Algorithm
August 2023 | Volume 22 | Issue 8 | Department | SF386361s1 | Copyright © August 2023
Background: Variations in the epidemiology, clinical presentation, and disease course in skin of color (SOC) atopic dermatitis (AD) patients have been reported that may impact treatme...
Read MoreFULL SUPPLEMENT: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment
August 2023 | Volume 22 | Issue 8 | Department | SF381621s1 | Copyright © August 2023
Most patients with plaque psoriasis exhibit mild-to-moderate disease and topical therapies remain the mainstay treatment option for these patients. The use of topical steroids in combination with vita...
Read MoreOff-Label Use of Baricitinib in Dermatology
August 2023 | Volume 22 | Issue 8 | Original Article | 795 | Copyright © August 2023
The current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib ...
Read MoreNo Racial Differences Found in Access to Biologics: A Population-Based Study of Psoriasis Patients in the United States
August 2023 | Volume 22 | Issue 8 | Editorials | 835 | Copyright © August 2023
Background: Conflicting evidence exists regarding the role of race in access to biologics for patients with psoriasis. Objective: To compare biologic use among adult and pediatric Uni...
Read MoreMedia and other results for: ""